Develops novel peptide drugs aimed at treating cardiovascular patients with high cholesterol and triglyceride levels, focusing on conditions like Homozygous Familial Hypercholesterolemia and potential indications in acute coronary syndrome, peripheral artery disease, and type 2 diabetes.